Model Calculations to Quantify Clinical and Economic Effects of Pathogen Inactivation in Platelet Concentrates

Publisher： Karger

E-ISSN： 2296-5262|36|1-2|53-59

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.36, Iss.1-2, 2013-01, pp. : 53-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Platelet Concentrates with the Mirasol Pathogen Inactivation System Modulates Platelet Oxidative Stress and NF-κB Activation

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 3, 2015-05 ,pp. : 167-173

Karger

Access to resources Recommend Favorite

Pathogen inactivation of double‐dose buffy‐coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function

By  

VOX SANGUINIS, Vol. 108, Iss. 4, 2015-05 ,pp. : 340-349

John Wiley & Sons Inc

Access to resources Recommend Favorite

Storage Characteristics of Split Double-Dose Platelet Concentrates Derived from Apheresis and Treated with Amotosalen Hydrochloride and UVA Light for Pathogen Inactivation

By  

Transfusion Medicine and Hemotherapy, Vol. 29, Iss. 4, 2002-08 ,pp. : 193-198

Karger

Access to resources Recommend Favorite

Tolerance of platelet concentrates treated with UVC‐light only for pathogen reduction – a phase I clinical trial

By  

VOX SANGUINIS, Vol. 109, Iss. 1, 2015-07 ,pp. : 44-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of the Clinical Performance of Platelet Concentrates Treated by Pathogen Reduction Technology in Santiago de Compostela

By  

Transfusion Medicine and Hemotherapy, Vol. 44, Iss. 1, 2016-10 ,pp. : 5-9

Karger

Access to resources Recommend Favorite